THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY. (2021). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), 23-37. https://doi.org/10.53366/jimki.v9i1.321